First look at 308 performance forecasts: over 80% of the forecasts are concentrated in the three industries

　　Our reporter Li Chunlian

　　Trainee reporter Wang Jingru Feng Yuyao

　　As of the press release on January 13, a total of 308 A-share listed companies have released 2021 annual performance forecasts.

Flush iFinD data shows that among the 308 companies, the performance forecast is over 80%, and the pre-increase, slight increase, continued profit, turnaround, and loss reduction are 171, 65, 13, 15, and 3 companies, accounting for 86.69% in total; In addition, there are 38 companies with pre-decrease, slight decrease, first loss, increase of loss, and continuous loss in performance; another 3 companies are uncertain.

　　Prehi companies focus on three industries

　　According to the industry classification of the China Securities Regulatory Commission, the 171 companies whose annual performance is expected to increase in 2021 are mainly concentrated in chemical raw material and chemical product manufacturing, computer communication and other electronic equipment manufacturing, and pharmaceutical manufacturing, with 41 companies (23.98%) and 25 companies respectively. (14.62%) and 10 (5.85%), accounting for 44.45% in total.

　　Qin Ruohan, general manager of Jinhua Fund, said in an interview with a reporter from "Securities Daily": "Major countries in the world are accelerating the research and development of vaccine-based innovative drugs, shortening the administrative approval process, and superimposing the catalysis of the epidemic on the demand for testing products, which directly stimulates The basic orientation of pharmaceutical-related companies is good.”

　　Taking Kapu Bio, which is mainly engaged in molecular diagnostic products and services, as an example, the company expects to make a profit of 800 million to 860 million yuan in 2021, an increase of 120.59% to 137.14% over the same period of the previous year.

The company stated that during the reporting period, it continued to promote the integrated business model of "nucleic acid testing products + medical testing services", and continued to implement the "nucleic acid 99 strategy" and the "Kaipu B53 nucleic acid remote strategic service plan". The company's third-party medical laboratory ( (including Hong Kong) actively participated in the prevention and control of the new crown epidemic, and the business achieved rapid development.

　　Regarding the performance of listed companies in the computer communication and other electronic equipment manufacturing industries, Chen Mengjie, chief strategist of Yuekai Securities, told the Securities Daily reporter: "Computer communication has benefited from the wave of intelligence, and the fields of intelligent driving and Internet of Vehicles are gaining momentum. In addition, the penetration rate of cloud computing, big data and other technology applications has increased, which also supports the continuous growth of the industry; the implementation of industry modules of new infrastructure such as 5G projects has driven the continuous improvement of the operating conditions of leading companies."

　　Liyang Chip stated in its performance forecast that with the vigorous development of the domestic integrated circuit industry, the industry's prosperity has continued to improve.

The company has full test orders in the second half of 2021, and its production capacity is running at full capacity.

The company's fourth-quarter operating income is expected to be 134 million yuan to 159 million yuan, a record high in a single quarter since the company was established.

　　Yangjie Technology said that in 2021, benefiting from the favorable policies issued by countries and regions and the pull of the downstream market, the company seized the opportunity of accelerating domestic substitution of power semiconductors, increased market development efforts, and accelerated the release of new production capacity. During the reporting period, the group operated Revenue grew by more than 60% year over year.

　　Hebang Bio temporarily resides in the "pre-growth king"

　　According to the arrangement, according to the performance growth rate (calculated based on the upper limit of the forecasted net profit year-on-year growth rate), Hebang Bio is temporarily ranked first in the 2021 annual performance forecast growth list, with an expected year-on-year growth of up to 7960.09%.

　　The company stated in its performance forecast that its main products are glyphosate, glyphosate, soda ash, ammonium chloride, and glass. Benefiting from increased environmental protection requirements and the further clearance of backward production capacity caused by the epidemic, production capacity expansion is limited, and downstream demand is superimposed. growth, thereby driving up sales prices and enabling the company to obtain a reasonable operating profit.

　　In addition, among the companies whose net profit has increased by more than 100%, it is worth noting that many non-ferrous metal companies are among them.

For example, Mount Everest in Tibet expects a year-on-year increase of up to 2842.69% in net profit in 2021.

In addition, non-ferrous metal companies such as Huayou Cobalt and Panzhihua Iron and Steel Vanadium and Titanium are expected to have the highest year-on-year growth in net profit of 260.56% and 262.29% respectively.

　　"Non-ferrous metals are commodities, and the profits of this industry depend to a large extent on international commodity prices. Last year, the major central banks of various countries adopted monetary easing policies, which began to play a role in stimulating demand." Cheng Yu, a senior researcher at the Institute of Understanding "Securities Daily" reporter said.

　　Driven by commodity prices, the prices of non-ferrous metals including zinc, lead, cobalt, copper, aluminum, molybdenum, etc. will rise in 2021.

"The price of non-ferrous metals has continued to rise and once hit a new high in recent years, opening up profit growth space for companies engaged in this type of business." Wang Guoqing, director of Lange Steel Research Center, said in an interview with a reporter from Securities Daily.

　　The first loss of many thermal power companies

　　At the "tail end" of the performance ranking, some companies are not having a good time, and even fall into the "first loss".

　　Under the contradiction between coal and electricity, thermal power companies have become the first and worst-hit areas. The reporter noticed that, according to the forecast net profit ranking, 4 of the 5 pre-loss companies at the "tail end" are thermal power companies. Among them, Jinshan Co., Ltd. is expected to The net profit attributable to shareholders of the listed company will lose 1.8 billion yuan to 2.038 billion yuan, a year-on-year decrease of 1.882 billion yuan to 2.120 billion yuan.

　　Regarding the performance losses, the above-mentioned thermal power companies have explained the reasons, saying that coal prices have risen sharply year-on-year, and the costs of power generation and heating have been inverted.

Hu Qimu, chief researcher of Sinosteel Economic Research Institute, explained to the "Securities Daily" reporter: "The rapid and sharp rise in thermal coal prices in 2021 will greatly increase the cost of thermal power companies. Profits have been significantly compressed by rising costs."

　　In addition to the deep losses of many thermal power companies, there are also many cases of performance decline due to changes in the market environment.

Calculated based on the year-on-year increase in the forecasted net profit, a company's performance has dropped by 47 times due to changes in the downstream market, and the decline temporarily ranks first.

　　The company pointed out in the performance forecast that due to the far-reaching changes in the development structure of the downstream industry, the technical requirements of customers for products have been increasing, and the transformation of product specifications has accelerated. As a result, the increase in the provision for inventory depreciation reserves will affect the current performance.

　　In addition, some companies such as *ST Huasu said that due to the continued impact of the epidemic, the company's exhibition service sector has increased losses, and its net profit has turned from profit to loss, with an estimated loss of 4 million to 6 million yuan.

(Securities Daily)